NEUROCHEMICAL VARIABLES IN SCHIZOPHRENIC-PATIENTS DURING SWITCHING FROM NEUROLEPTICS TO CLOZAPINE

Citation
J. Hatzimanolis et al., NEUROCHEMICAL VARIABLES IN SCHIZOPHRENIC-PATIENTS DURING SWITCHING FROM NEUROLEPTICS TO CLOZAPINE, Progress in neuro-psychopharmacology & biological psychiatry, 22(7), 1998, pp. 1077-1085
Citations number
27
Categorie Soggetti
Neurosciences,"Clinical Neurology","Pharmacology & Pharmacy",Psychiatry
ISSN journal
02785846
Volume
22
Issue
7
Year of publication
1998
Pages
1077 - 1085
Database
ISI
SICI code
0278-5846(1998)22:7<1077:NVISDS>2.0.ZU;2-3
Abstract
1. The study aimed to search for the effect of clozapine on the levels of the main metabolites of dopamine homovanillic acid (HVA), serotoni n 5-hydroxyindoleacetic acid (5-HIAA) and norepinephrine 3-methoxy-4-h ydroxyphenylglycol (MHPG) in urine als well as on plasma levels of HVA , 5-HIAA, prolactin (PRL) and cortisol. 2. Seventeen male patients dia gnosed as suffering from DSM-IIIR schizophrenia completed the study. 3 . The patients were switched from classical antipsychotics to clozapin e. After six weeks treatment with clozapine the severity of psychopath ology (total BPRS score) decreased significantly (p=0.00004). pHVA and -5-HIAA did not change significantly. uMHPG increased significantly ( p=0.017). Both PRL and cortisol levels decreased significantly (p=0.00 02, p=0.032 respectively). Patients with high HVA levels in both plasm a and urine at baseline had a lower BPRS score at the end of treatment period (p=0.0001, p=0.049 respectively).